TY - JOUR
T1 - Correlation of procalcitonin and cytokine expression with dehiscence of wartime extremity wounds
AU - Forsberg, Jonathan Agner
AU - Elster, Eric A.
AU - Andersen, Romney C.
AU - Nylen, Eric
AU - Brown, Trevor S.
AU - Rose, Matthew W.
AU - Stojadinovic, Alexander
AU - Becker, Kenneth L.
AU - McGuigan, Francis Xavier
PY - 2008/3
Y1 - 2008/3
N2 - Background: Despite technological advances in the treatment of severe extremity trauma, the timing of wound closure remains the subjective clinical decision of the treating surgeon. Traditional serum markers are poor predictors of wound-healing. The objective of this study was to evaluate the cytokine and chemokine profiles of severe extremity wounds prior to closure to determine if wound effluent markers can be used to predict healing. Methods: Serum and effluent (exudate) samples were collected prospectively from adult volunteers with multiple high-energy penetrating extremity wounds sustained during military combat. Samples were collected prior to definitive wound closure or flap coverage. Wounds were followed clinically for six weeks. The primary clinical outcome measures were wound-healing and dehiscence. Control serum samples were collected from normal age and sex-matched adult volunteers. All samples were analyzed for the following cytokines and chemokines: procalcitonin; eotaxin; granulocyte macrophage colony stimulating factor; interferon (IFN)-γ; interleukin (IL)-1 through 8, KD, 12, 13, and 15; IFN-γ inducible protein-10; monocyte chemotactic protein-1; macrophage inflammatory protein-1α the protein regulated on activation, normal T expressed and secreted (RANTES); and tumor necrosis factor (TNF)-α. Results: Fifty wounds were analyzed in twenty patients. Four of the fifty wounds dehisced. An increased rate of wound dehiscence was observed in patients with a concomitant closed head injury as well as in those with an associated arterial injury of the affected limb (p < 0.05). Among the serum chemokines and cytokines, only serum procalcitonin levels correlated with wound dehiscence (p < 0.05). Effluent analysis showed that, compared with wounds that healed, wounds that dehisced were associated with elevated procalcitonin, decreased RANTES protein, and decreased IL-13 concentrations (p < 0.05). No wound with an effluent procalcitonin concentration of <220 pg/mL, an IL-13 concentration of >12 pg/mL, or a RANTES protein concentration of >1000 pg/mL failed to heal. Conclusions: Effluent procalcitonin, IL-13, and RANTES protein levels as well as serum procalcitonin levels correlate with wound dehiscence following closure of severe open extremity wounds. These preliminary results indicate that effluent biomarker analysis may be an objective means of determining the timing of traumatic wound closure. Level of Evidence: Prognostic Level I. See Instructions to Authors for a complete description of levels of evidence.
AB - Background: Despite technological advances in the treatment of severe extremity trauma, the timing of wound closure remains the subjective clinical decision of the treating surgeon. Traditional serum markers are poor predictors of wound-healing. The objective of this study was to evaluate the cytokine and chemokine profiles of severe extremity wounds prior to closure to determine if wound effluent markers can be used to predict healing. Methods: Serum and effluent (exudate) samples were collected prospectively from adult volunteers with multiple high-energy penetrating extremity wounds sustained during military combat. Samples were collected prior to definitive wound closure or flap coverage. Wounds were followed clinically for six weeks. The primary clinical outcome measures were wound-healing and dehiscence. Control serum samples were collected from normal age and sex-matched adult volunteers. All samples were analyzed for the following cytokines and chemokines: procalcitonin; eotaxin; granulocyte macrophage colony stimulating factor; interferon (IFN)-γ; interleukin (IL)-1 through 8, KD, 12, 13, and 15; IFN-γ inducible protein-10; monocyte chemotactic protein-1; macrophage inflammatory protein-1α the protein regulated on activation, normal T expressed and secreted (RANTES); and tumor necrosis factor (TNF)-α. Results: Fifty wounds were analyzed in twenty patients. Four of the fifty wounds dehisced. An increased rate of wound dehiscence was observed in patients with a concomitant closed head injury as well as in those with an associated arterial injury of the affected limb (p < 0.05). Among the serum chemokines and cytokines, only serum procalcitonin levels correlated with wound dehiscence (p < 0.05). Effluent analysis showed that, compared with wounds that healed, wounds that dehisced were associated with elevated procalcitonin, decreased RANTES protein, and decreased IL-13 concentrations (p < 0.05). No wound with an effluent procalcitonin concentration of <220 pg/mL, an IL-13 concentration of >12 pg/mL, or a RANTES protein concentration of >1000 pg/mL failed to heal. Conclusions: Effluent procalcitonin, IL-13, and RANTES protein levels as well as serum procalcitonin levels correlate with wound dehiscence following closure of severe open extremity wounds. These preliminary results indicate that effluent biomarker analysis may be an objective means of determining the timing of traumatic wound closure. Level of Evidence: Prognostic Level I. See Instructions to Authors for a complete description of levels of evidence.
UR - http://www.scopus.com/inward/record.url?scp=40349114909&partnerID=8YFLogxK
U2 - 10.2106/JBJS.G.00265
DO - 10.2106/JBJS.G.00265
M3 - Article
C2 - 18310708
AN - SCOPUS:40349114909
SN - 0021-9355
VL - 90
SP - 580
EP - 588
JO - Journal of Bone and Joint Surgery
JF - Journal of Bone and Joint Surgery
IS - 3
ER -